Skip to main content
Article thumbnail
Location of Repository

Alpha-tocopherol: looking beyond an antioxidant

By Kaya Nusret Engin

Abstract

Vitamin E is an important natural antioxidant, and its most common and biologically active form is α-tocopherol. In addition to this, specific regulatory effects of vitamin E have been revealing. The body exerts a certain effort to regulate its tissue levels with specific tocopherol transport proteins and membrane receptors. Antiproliferative and protein kinase C-supressing effects of alpha-tocopherol have been previously demonstrated, which have not been mimicked by beta-tocopherol or probucol. Protein kinase C promises to be an important area of interest in the means of glaucoma and cataractogenesis. It has been shown in different models that retinal vasculer dysfunction due to hyperglycemia could be prevented by alpha-tocopherol via the diachylglycerol-protein kinase C pathway. Glutamate transporter activity has been shown to be modulated by protein kinase C. This pathway is also important in intraocular pressure-lowering effects of prostaglandin and its analogs in glaucoma therapy. Filtran surgery became another possible area of usage of alpha-tocopherol since its antiproliferative effect has been demonstrated in human Tenon's capsule fibroblasts. Prevention of posterior capsule opacification is another area for future studies. It is evident that when correct and safe modulation is the objective, alpha-tocopherol merits a concern beyond its mere antioxidant properties

Topics: Review
Publisher: Molecular Vision
OAI identifier: oai:pubmedcentral.nih.gov:2672149
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2000). A novel human tocopherol-associated protein: cloning, in vitro expression, and characterization.
    2. (2001). Abdel-Latif AA. Effects of prostaglandin F(2alpha) and carbachol on MAP kinases, cytosolic phospholipase A(2) and rachidonic acid release in cat iris sphincter smooth muscle cells. Exp Eye Res
    3. (2001). Acott TS. Involvement of protein kinase C in TNFalpha regulation of trabecular matrix metalloproteinases and TIMPs. Invest Ophthalmol Vis Sci
    4. (1991). Activation of protein kinase C decreases proliferation of c-jun at sites that negatively regulate its DNA binding activity. Cell
    5. (2000). Alpha-tocopherol derivatives and wound healing in an experimental model of filtering surgery. Ophthalmic Surg Lasers
    6. (1999). Alpha-tocopherol derivatives in an experimental model of filtering surgery. Ophthalmic Res
    7. (1992). An activator of protein kinase C inhibits gap junction communication between cultured bovine lens cells. Exp Cell Res
    8. (2002). Antagonists of protein kinase C inhibit rat retinal glutamate transport activity in situ.
    9. (1996). Calpains in the human lens: relations to membranes and possible role in cataract formation. Ophthalmic Res
    10. (2007). Clinical evaluation of the neuroprotective effect of α-tocopherol on retına against glaucomatous damage.
    11. (2001). Clinicopathological report of retinitis pigmentosa with vitamin E deficiency caused by mutation of the alphatocopherol transfer protein gene.
    12. (1996). Cross talk between cyclic AMP and the polyphosphoinositide signaling cascade in iris sphincter and other nonvascular smooth muscle.
    13. (1999). d-α-tocopherol prevents the hyperglycemia induced activation of diacylglycerol (DAG)-protein kinase C (PKC) pathway in vascular smooth muscle cell by an increase of DAG kinase activity. Diabetes Res Clin Pract
    14. (1994). Determinants of plasma vitamin E concentrations. Free Radic Biol Med
    15. (1990). Early proto-oncogene expression in rat aortic smooth muscle cells following endothelial removal.
    16. (2002). Effect of protein kinase Cgamma on gap junction disassembly in lens epithelial cells and retinal cells in culture. Mol Vis
    17. (1993). Evidence for the photoprotective effects of vitamin E. Photochem Photobiol
    18. (2007). Functional involvement of scavenger receptor class B, type I, in the uptake of alphatocopherol using cultured rat retinal capillary endothelial cells. Mol Vis
    19. (1995). Human α-tocopherol transfer protein: cDNA cloning, expression and chromozomal location.
    20. (2006). Hydrophobic acrylic and plate-haptic silicone intraocular lens implantation in diabetic patients: pilot randomized clinical trial. J Cataract Refract Surg
    21. (1995). In vivo inhibition of lens regrowth by fibroblast growth factor 2-saporin. Invest Ophthalmol Vis Sci
    22. (1998). Influence of vitamin E succinate on retinal cell survival. Toxicology
    23. (1991). Inhibition of cell proliferation by α-tocopherol. Role of protein kinase.
    24. (1993). Inhibition of protein kinase Cζ subspecies blocks the activation of an NFκB−like activity in Xenopus Laevis oocytes. Mol Cell Biol
    25. (1993). Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. Biochim Biophys Acta
    26. (2001). Intracameral and lenticular penetration of locally applied stable isotope-labeled vitamin E.
    27. (1997). Leong FL, Refojo MF. Antiproliferative effect of intravitreal alpha-tocopherol and alpha-tocopheryl-acid-succinate in a rabbit model of PVR. Curr Eye Res
    28. (1993). lipoprotein transport and regulation of plasma concentrations of vitamin E in humans.
    29. (2009). Mechanical loading stimulates cell hypertrophy and specific gene expression in cultured rat Molecular Vision
    30. (1981). Membrane transfer of α-tocopherol.
    31. (2007). Molecular mechanism of alpha-tocopherol action. Free Radic Biol Med
    32. (1994). Na(+)-Cl(-)-K+ cotransport activity in cultured bovine lens epithelial cells and its absence in intact bovine lenses. Exp Eye Res
    33. (2000). Overexpression of protein kinase Cgamma inhibits gap junctional intercellular communication in the lens epithelial cells. Exp Eye Res
    34. (2009). pH-dependent translocation of alphaMolecular Vision
    35. (2001). PKCalpha and PKCgamma overexpression causes lentoid body formation in the N/N 1003A rabbit lens epithelial cell line.
    36. (1999). Posterior capsular opacification after cataract surgery. Eye
    37. (1992). Posterior capsular opacification. Surv Ophthalmol
    38. (1998). Prevention of atherosclerosis by α-tocopherol in smooth muscle cells by a mechanism involving signal transduction modulation. In: Özben T, editors. Free radicals, oxidative stress and antioxidants.
    39. (2009). Prevention of lens damage associated with cigarette smoke exposure in rats by alpha-tocopherol (vitamin E) treatment. Invest Ophthalmol Vis Sci 1999; 40:537-41. [PMID: 9950617] Molecular Vision
    40. (1999). Protective function of alpha-tocopherol against the process of cataractogenesis in humans. Ann Nutr Metab
    41. (1991). Protective role of Vitamin E in biological systems.
    42. (1993). Protein kinase C activity and its relationship to myo-inositol uptake during hyperglycemic conditions in cultured bovine lens epithelial cells. Curr Eye Res
    43. (1991). Purification and characterization of α−tocopherol transfer protein from rat liver.
    44. (1993). Purification and partial caracterization of an α-tocopherol binding protein from rabbit heart cytosol. Mol Cell Biochem
    45. (1998). Regulation of aquaporin-4 water channels by phorbol ester-dependent protein phosphorylation.
    46. (2001). Regulation of c-fos induction in lens epithelial cells by 12(S)HETE-dependent activation of PKC. Invest Ophthalmol Vis Sci
    47. (1997). Regulation of protein kinase C. Curr Opin Cell Biol
    48. (1997). Retinal light damage: protective effect of alpha-tocopherol.
    49. (1986). retinal, choroidal vitreal Vitamin E concentrations in human infants. Pediatrics
    50. (1991). Role of tocopherols in the protection of biological systems against oxidative damage.
    51. (1990). RRR-alpha tocopherol potentiates prostacyclin release in human endothelial cells. Evidence for structural specifity of tocopherol molecule. Biochim Biophys Acta
    52. (1994). Screening of potential chemopreventive agents using biochemical markers of carcinogenesis.
    53. (1995). Serum antioxidants and age-related macular degeneration in a population-based casecontrol study. Arch Ophthalmol
    54. (1999). Serum carotenoids and tocopherols and incidence of age-related nuclear cataract.
    55. (1985). Severe retinopathy of prematurity in infants with birth weights less than 1250 grams: incidence and outcome of treatment with pharmacologic serum levels of vitamin E in addition to cryotherapy from
    56. (1994). Signal transduction in vascular smooth muscle: Diacylglycerol second messengers and PKC action.
    57. (1987). Snoek GT. EDTAextractable proteins from calf lens fiber membranes are phosphorylated by Ca2+-phospholipid-dependent protein kinase. Exp Eye Res
    58. (1996). Strategies to prevent lens cell growth causing posterior capsule opacification: An in vitro study.
    59. (2000). The regulation of trabecular meshwork and ciliary muscle contractility. Prog Retin Eye Res
    60. (2005). Tocotrienol inhibits proliferation of human Tenon’s 's fibroblasts in vitro: a comparative study with vitamin E forms and mitomycin C. Graefes Arch Clin Exp Ophthalmol
    61. (1993). Transcriptional enhance factor-1 in cardiac myocytes interacts with an α1 adrenergic and β protein kinase C-inducible element in the rat β-myosin heavy chain promoter.
    62. (1996). UV-induced changes in cell cycle and gene expression within rabbit lens epithelial cells. Photochem Photobiol
    63. (1987). Vitamin E and rabbit corneal endothelial cell survival.
    64. (1995). Vitamin E beyond antioxidant function.
    65. (2001). Vitamin E inhibition of normal mammary epithelial cell growth is associated with a reduction in protein kinase C(alpha) activation. Cell Prolif
    66. (1996). Vitamin E inhibits proliferation of human Tenon's capsule fibroblasts in vitro. Ophthalmic Res
    67. (1994). Vitamin E inhibits retinal pigment epithelium cell proliferation in vitro. Ophthalmic Res
    68. (1995). Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway.
    69. (1996). Vitamin E succinate inhibits proliferation and migration of retinal pigment epithelial cells in vitro: therapeutic implication for proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol
    70. (1999). Vitamin E: Function and metabolism.
    71. (1992). Vitamin E: Inhibition of retinol induced hemolysis and membrane stabilizing behavior.
    72. (2000). Vitamin E: non-antioxidant roles. Prog Lipid Res

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.